Psyomics - company
3 known investors
Find your way into Psyomics - company
779 people in our graph share verified history with the Psyomics - company team — schools, employers, funds. One of them is your warm intro.
Drew Burdonunlockedknows Rupert Hipwell · together at The Open University (overlapped)
×3knows the team · via University of Cambridge
knows the team · via University of Bristol
×3knows the team · via London Business School
×2knows the team · via Harvard Business School
knows the team · via Congenica
Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people. The company is also developing a dry blood spot biomarker test to distinguish Major Depressive Disorder from Bipolar disorder to reduce misdiagnosis.
Founders & leadership
DM
Dr. Melinda ReesinChief Executive OfficerDr. Melinda Rees is a registered clinical psychologist with 25+ years of clinical leadership experience in the NHS, followed by a decade in strategic healthcare leadership roles in the independent sector. She is CEO of Psyomics, which develops behavioral health assessment tools and biomarker tests for mental health diagnosis.
RH
Rupert HipwellinChief Commercial OfficerRupert Hipwell is Chief Commercial Officer of Psyomics, where he leads strategy and operations. He has held senior management roles in healthcare and life sciences focused on corporate development, marketing, and sales, with experience launching and scaling ventures.
AN
Alex NancekievillinChief Technology OfficerAlex Nancekievill is Chief Technology Officer at Psyomics. He has 24 years of experience developing medical devices and software across biotech and healthcare, including leading product development at Asymptote (sold to GE Healthcare) and HBSUK (sold to AXA Health), where he worked on regulated medical device platforms, machine learning applications, and NHS Digital integrations.
Investors · 3
Frequently asked questions
- What does Psyomics - company do?
- Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people. The company is also developing a dry blood spot biomarker test to distinguish Major Depressive Disorder from Bipolar disorder to reduce misdiagnosis.
- Who are Psyomics - company's investors?
- Psyomics - company's investors include Cambridge Angels group, EMV Capital, Martlet Capital.